A Clinical Investigation of the Taperloc® Microplasty™ Hip System

NCT00699309 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 98

Last updated 2017-06-21

No results posted yet for this study

Summary

The purpose of this prospective clinical data-collection is to document the performance and clinical outcomes of the Taperloc® Microplasty™ Hip System.

Conditions

Sponsors & Collaborators

  • Biomet Orthopedics, LLC

    lead INDUSTRY

Principal Investigators

  • Russell Schenck, PhD · Director, Clinical Research, Biomet Orthopedics, LLC

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-08-31
Primary Completion
2013-03-31
Completion
2013-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00699309 on ClinicalTrials.gov